Randomized trial of FOLFOX alone or combined with atezolizumab as adjuvant therapy for patients with stage III colon cancer and deficient DNA mismatch repair or microsatellite instability (ATOMIC, Alliance A021502) Meeting Abstract
| Authors: | Sinicrope, F. A.; Ou, F. S.; Shi, Q.; Nixon, A. B.; Mody, K.; Levasseur, A.; Dueck, A. C.; Dhanarajan, A. R.; Lieu, C. H.; Cohen, D. J.; Innocenti, F.; Behrens, R. J.; Peters, W.; Sargent, D. J.; Sommer, N.; O'Reilly, E. M.; Meyerhardt, J. |
| Abstract Title: | Randomized trial of FOLFOX alone or combined with atezolizumab as adjuvant therapy for patients with stage III colon cancer and deficient DNA mismatch repair or microsatellite instability (ATOMIC, Alliance A021502) |
| Meeting Title: | 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 35 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2017 Jun 2-6 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2017-05-20 |
| Start Page: | 198s |
| Language: | English |
| ACCESSION: | WOS:000411895707111 |
| DOI: | 10.1200/JCO.2017.35.15_suppl.TPS3630 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS3630 -- Source: Wos |
